The store will not work correctly when cookies are disabled.
(2-chlorophenyl)(4-(3-chlorophenyl)pyrrolo[1,2-a]pyrazin-3-yl)methanone
ID: ALA4291752
PubChem CID: 145989604
Max Phase: Preclinical
Molecular Formula: C20H12Cl2N2O
Molecular Weight: 367.24
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(c1ccccc1Cl)c1ncc2cccn2c1-c1cccc(Cl)c1
Standard InChI: InChI=1S/C20H12Cl2N2O/c21-14-6-3-5-13(11-14)19-18(23-12-15-7-4-10-24(15)19)20(25)16-8-1-2-9-17(16)22/h1-12H
Standard InChI Key: XWXMRLQEWRBKJN-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
29.1928 -4.5221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1936 -5.3469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9030 -4.1111 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.2259 -2.8683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9449 -3.2774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6502 -2.8555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6412 -2.0301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9209 -1.6283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2144 -2.0483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3696 -3.2621 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
28.4764 -5.7596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4769 -6.5837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1928 -6.9941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9054 -6.5786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9014 -5.7559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6145 -5.3381 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
28.4838 -4.1187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5160 -3.2909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0533 -4.0629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7546 -4.5071 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.0856 -3.2350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8147 -2.8490 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.6729 -2.0362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8560 -1.9199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4932 -2.6609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17 1 1 0
1 2 1 0
1 3 2 0
18 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
6 10 1 0
2 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 2 1 0
15 16 1 0
17 18 2 0
17 20 1 0
18 22 1 0
21 19 1 0
19 20 2 0
21 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 21 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 367.24 | Molecular Weight (Monoisotopic): 366.0327 | AlogP: 5.54 | #Rotatable Bonds: 3 |
Polar Surface Area: 34.37 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.01 | CX LogD: 5.01 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.45 | Np Likeness Score: -1.48 |
References
1. Doebelin C, Patouret R, Garcia-Ordonez RD, Chang MR, Dharmarajan V, Novick S, Ciesla A, Campbell S, Solt LA, Griffin PR, Kamenecka TM.. (2018) Identification of potent RORβ modulators: Scaffold variation., 28 (19): [PMID:30143422] [10.1016/j.bmcl.2018.08.017] |